inclusion criteria: * subject ≥ 18 years, signing the informed consent. * sars-cov-2 infection by pcr ≤ 7 days * one or more of covid-19 related symptoms or measured fever present within 48 hours prior to study entry (subjects with mild-moderate covid-19)

inclusion criteria: * subject ≥ 18 years, signing the informed consent. * sars-cov-2 infection by pcr ≤ 7 days * one or more of covid-19 related symptoms or measured fever present within 48 hours prior to study entry (subjects with mild-moderate covid-19)

inclusion criteria: - subject ≥ 18 years, signing the informed consent. - sars-cov-2 infection by pcr ≤ 7 days - one or more of covid-19 related symptoms or measured fever present within 48 hours prior to study entry (subjects with mild-moderate covid-19)

inclusion criteria: - subject ≥ 18 years, signing the informed consent. - sars-cov-2 infection by pcr ≤ 7 days - one or more of covid-19 related symptoms or measured fever present within 48 hours prior to study entry (subjects with mild-moderate covid-19)